February 14, 2026

@michaelokun

Mini-brains in a dish reveal hidden inflammation in Parkinson’s disease. What are organoids? Organoids are three dimensional clusters of human cells grown from stem cells that mimic key features of real brain tissue, but do it in the confines of a laboratory dish. Barmpa and colleagues describe in a new paper in Movement Disorders how patient specific striatum organoids derived from induced pluripotent stem cells can model early Parkinson’s disease biology outside the human brain. Key Points: - Patient specific striatum organoids carrying the LRRK2 G2019S mutation showed higher levels of DRD2, DARPP32 and CDK5, suggesting altered dopamine signaling in the indirect basal ganglia pathway. - Proteomics and kinase analyses revealed a strong inflammatory signature, including upregulation of cytokines, chemokines and SRC family kinases. - Reactive astrocytes marked by GFAP, S100B and B2MG were significantly increased in Parkinson’s derived organoids, even in the absence of dopaminergic input. My take: This study shifts the focus from the dying dopamine neuron alone to the neighborhood around it. These mini-brains suggest that the striatum itself may be primed for inflammation and altered signaling before classic degeneration is fully established. That concept should get our attention. Here are 5 points that resonated w/ me: 1- Parkinson’s disease may not start only in the substantia nigra, the striatum may independently develop pathological features. 2- The LRRK2 G2019S mutation appears to bias signaling toward the DRD2 indirect pathway, which is tightly linked to motor control. 3- Inflammation and reactive astrocytes may possibly be early and autonomous drivers of dysfunction, not just secondary bystanders. 4- Patient specific organoids allow us to study human disease biology in a dish, opening doors to personalized therapeutic testing. 5- If we can identify inflammatory and signaling changes before major dopamine loss, we may be able to intervene earlier and more precisely for folks living w/ Parkinson’s disease. https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.70176 #michaelokun #fixelinstitute #parkinson